Investor Relations

Here you will find details on our share as well as detailed information on key figures, annual and quarterly results, IR events and much more.

Rating & Research

Here you will find well-founded stock analyses of renowned research houses and banks on the HAEMATO AG share.

BUY: 6.15 €

GBC AG

27 May 2019

Read the study

ADD: 5.80 €

First Berlin Equity Research

17 May 2019

Read the study

BUY: 7.60 €

First Berlin Equity Research

13 September 2018

Read the study

BUY: 7.90 €

GBC AG

11 September 2018

Read the study

BUY: 7.70 €

First Berlin Equity Research

23 May 2018

Read the study

BUY: 8.00 €

GBC AG

16 May 2018

Read the study

BUY: 7.40 €

First Berlin Equity Research

4 October 2017

Read the study

BUY: 7.35 €

GBC AG

15 September 2017

Read the study

BUY: 8.55 €

GBC AG

12 May 2017

Read the study

BUY: 8.40 €

First Berlin Equity Research

9 May 2017

Read the study

BUY: 7.45 €

GBC AG

20 March 2017

Read the study

BUY: 8.40 €

First Berlin Equity Research

17 March 2017

Read the study

BUY: 7.00 €

First Berlin Equity Research

07 December 2016

Read the study

BUY: 7.45 €

GBC AG

05 December 2016

Read the study

BUY: 7.00 €

First Berlin Equity Research

05. September 2016

Read the Study

BUY: 7.45 €

GBC AG

02 September 2016

Read the study

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag

LINKS

Imprint
Data Protection
Contact

HAEMATO Group

HAEMATO AG
HAEMATO PHARM GmbH
HAEMATO MED GmbH